These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 2778486)

  • 1. Drug resistance in brain tumors.
    Feun LG; Savaraj N; Landy HJ
    J Neurooncol; 1994; 20(2):165-76. PubMed ID: 7807193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
    Dalton WS; Grogan TM; Meltzer PS; Scheper RJ; Durie BG; Taylor CW; Miller TP; Salmon SE
    J Clin Oncol; 1989 Apr; 7(4):415-24. PubMed ID: 2564428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study.
    Dalton WS; Crowley JJ; Salmon SS; Grogan TM; Laufman LR; Weiss GR; Bonnet JD
    Cancer; 1995 Feb; 75(3):815-20. PubMed ID: 7828131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD).
    Maniatis A; Stamatellou M; Papanastasiou K
    Chemioterapia; 1987 Jun; 6(2 Suppl):727-8. PubMed ID: 3509532
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].
    Monconduit M; Le Loët X; Bernard JF; Menard JF; Grosbois B; Michaux JL; De Gramont A; Laporte JP; Najman A; Jouet JP
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):477-9. PubMed ID: 3616472
    [No Abstract]   [Full Text] [Related]  

  • 6. [The influence of verapamil on platelet function in patients with multiple myeloma].
    Sokołowska B; Dmoszyńska A; Walter-Croneck A; Wojtaszko M
    Pol Merkur Lekarski; 1997 Feb; 2(8):109-10. PubMed ID: 9538652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trials of modulating the MDR1 phenotype in malignant hemopathies].
    Marie JP; Zhou D; Delmer A; Zittoun R
    Bull Cancer; 1994 Dec; 81 Suppl 2():88s-90s. PubMed ID: 7727868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of multiple myeloma.
    Reizenstein P
    Leuk Res; 1989; 13(3):199-201. PubMed ID: 2651810
    [No Abstract]   [Full Text] [Related]  

  • 9. Addition of verapamil to overcome drug resistance in multiple myeloma: preliminary clinical observations in 10 patients.
    Trümper LH; Ho AD; Wulf G; Hunstein W
    J Clin Oncol; 1989 Oct; 7(10):1578-9. PubMed ID: 2778486
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
    Lila AM; Mazurov VI; Novik AA
    Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.